NRAS mutations are found in various malignancies including melanoma (20%), adenocarcinoma of the lung (1%), neuroblastoma (0.83%) and cutaneous T-cell lymphoma (4%). The gene discussed is NRAS; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.